JAK1 pathway inhibitors for the treatment of chronic lung allograft dysfunction

MYPI2025002390A0Undetermined Publication Date: 2020-09-05INCYTE CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025002390
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-03-05
Filing Date
2020-03-05
Publication Date
2020-09-05
Patent Text Reader

Abstract

This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome. [NO FIGURE]
Need to check novelty before this filing date? Find Prior Art